BSW Wealth Partners’s Aerie Pharmaceuticals AERI Stock Holding History

BSW Wealth Partners’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-20,750	Closed	-$314K	–	334
2022 Q3	$314K	Hold	20,750	–	–	0.08%	172
2022 Q2	$156K	Sell	20,750 -6,250	-23%	-$44K	0.04%	263
2022 Q1	$246K	Buy	+27,000	New	+$208K	0.06%	235

BSW Wealth Partners's AERI Position: Q4 2022 in Review

BSW Wealth Partners sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 20,750 shares — an estimated $314K sold.

BSW Wealth Partners first reported a position in AERI in Q1 2022 and held it in 3 quarters. The position peaked at $314K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

BSW Wealth Partners reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
BSW Wealth Partners sold 20,750 Aerie Pharmaceuticals shares in Q4 2022, an estimated $314K.
BSW Wealth Partners first reported a position in Aerie Pharmaceuticals in Q1 2022 and held it in 3 quarters.
BSW Wealth Partners's Aerie Pharmaceuticals position peaked at $314K in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on BSW Wealth Partners's 13F filing for Q4 2022, filed 14 Feb 2023.